Skip to main content
Menu
Revvity logo
Contact us

Loading...

US
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Login/Register here
Revvity web shop online account

Get exclusive pricing on all online purchases.

Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.

Login Register
Revvity Omics portal accounts

Initiate a new order or access test status and results for clinical genomics or newborn screening services.

View login options
Breadcrumb
...
  • Home
  • Development and validation of customized guide RNA design and efficiency prediction tools for the Pin-point base editing platform
Development and validation of customized guide RNA design and efficiency prediction tools for the Pin-point base editing platform
Scientific Poster

Development and validation of customized guide RNA design and efficiency prediction tools for the Pin-point base editing platform

This scientific poster describes the development and validation of customized guide RNA design and efficiency prediction tools for the Pin-point base editing platform.

To facilitate and accelerate the development of applications based on the Pin-point platform, we created a custom tool to design gRNAs to target the gene of interest and to install base conversion, including those that would either introduce premature STOP codons or destroy splice sites to knockout the target gene. In addition, we performed a parallel cell-based screen to analyze the editing activity of two different Pin-point base editor configurations with gRNAs targeting thousands of target sequences.

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.

For research use only. Not for use in diagnostic procedures.

Download Resource

Development and validation of customized guide RNA design and efficiency prediction tools for the Pin-point base editing platform

Download Scientific Poster
Revvity Logo

Loading...

    ©2025 Revvity - All rights reserved

    Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.